ArticleScience bulletin2025

Proliferative T-regulatory cells as a biomarker for immune checkpoint inhibitor efficacy in nasopharyngeal carcinoma: a new frontier.

Ashish Dahal et al.PubMed ↗Publisher ↗

No numbers read from the abstract.